The global Vein Finder Market size was valued at US$ 42.1 Million in 2021 and is expected to reach US$ 86.8 Million by 2028. The market is further expected to grow at a CAGR of 10.9% during the forecast period. Innovations in vein finder technology are taking the medical devices sector by storm, with advanced vein finders backed by latest technologies acting as a …
Category Archives: Healthcare Trends
Coxsackievirus Infections Treatment Market is likely to propel to US$ 12.1 Billion by 2033 | FMI
The global coxsackievirus infections treatment market is currently valued at US$ 5.5 Billion in 2023 and is anticipated to expand at a CAGR of 8.2%. Owing to the technological advances in healthcare the market is likely to propel to US$ 12.1 Billion by 2033. Major factors driving the global coxsackievirus diagnostics market are increase in incidence of coxsackievirus infections, surge …
Wound Irrigation Systems Market is set to witness a CAGR of 2.6% and be valued at around US$ 347.3 Million by 2032
[250 Pages Report] The global wound irrigation systems market is expected to be worth $267.6 million by the end of 2022, and to grow at a 2.6% CAGR from 2022 to 2032. By 2032, the market is expected to be worth US$ 347.3 billion. In terms of product, acute wounds lead the wound irrigation systems market, accounting …
Aarskog Scott Syndrome Treatment Market value of US$ 6 Billion by registering a CAGR of 6.5% in the forecast period 2023 to 2033
During the forecast period 2023 to 2033, the Aarskog Scott syndrome treatment market is expected to grow at a value of 6.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Aarskog Scott syndrome treatment is expected to rise up to a market valuation of US$ 6 Billion. Ongoing clinical trials, increasing …
Thrombocytopenia Treatment Market is forecasted to reach a valuation of US$ 10 Billion from US$ 6 Billion in 2023
Future Market Insights in its latest report predicts Korea Thrombocytopenia Treatment Market to progress at around 3.5% to 4.0% CAGR between 2023 and 2033. Sales of thrombocytopenia medication in the global market are slated to rise at a CAGR of 5.2% throughout the forecast period (2023 to 2033). Introduction of new treatments and medications for thrombocytopenia in Korea has the potential …
Hutchinson Gilford Progeria Syndrome (HGPS) Therapeutics Market is expected to grow with an 8.5% CAGR from 2023 to 2033
During the forecast period 2023 to 2033, the Hutchinson Gilford progeria syndrome market is expected to grow at a value of 8.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Hutchinson Gilford progeria syndrome is expected to rise up to a market valuation of US$ 15,990 Million. Around 400 children worldwide …
Andersen Tawil Syndrome Treatment Market is expected to surpass an impressive valuation of US$ 1.9 Billion in 2023
As per a recently published study by Future Market Insights, the global Andersen Tawil syndrome treatment market is expected to surpass an impressive valuation of US$ 1.9 Billion in 2023 and is projected to reach US$ 4.2 Billion by 2033, with a CAGR of 8.26%. Rising government assistance, provision of incentives to pharmaceutical companies, increasing awareness among …
Automated Sample Storage Systems Market is expected to secure US$ 3,395.6 Million during the forecast period 2022 to 2032
[Report of 250 Pages] In 2022, it is anticipated that the market for automated sample storage systems will be worth US$ 992.5 million, rising to US$ 3,395.6 million in 2032. During the aforementioned time frame, a CAGR of 11.8% is forecast for the market. The rising demand for automated sample storage in industries like biotechnology, chemicals, pharmaceuticals, …
INR Test Meter Market is expected to reach US$ 2.4 Billion by the end of 2032 | FMI
[300+ Pages Report] The market for INR test metres is anticipated to reach US$ 1.3 billion by the end of 2022, growing at a CAGR of 6.3 percent, and surpassing US$ 2.4 billion by 2032. With a market share of approximately 79.7% in 2021, the devices segment dominated the global INR test metre market in …
Herpes Simplex Keratitis Treatment Market | GlaxoSmithKline, Vectans Pharma, Blistex, Bausch Health | By 2032
By 2022, it is anticipated that the Herpes Simplex Keratitis Treatment Market would reach US$ 4.2 billion. Market size is estimated to reach US$ 7.9 billion in 2032 and grow at a robust CAGR of 6.1% between 2022 and 2032. One of the main causes of ocular morbidity worldwide, along with CMV retinitis in AIDS, …